180 related articles for article (PubMed ID: 33039422)
21. Deep learning approach of diffusion-weighted imaging as an outcome predictor in laryngeal and hypopharyngeal cancer patients with radiotherapy-related curative treatment: a preliminary study.
Tomita H; Kobayashi T; Takaya E; Mishiro S; Hirahara D; Fujikawa A; Kurihara Y; Mimura H; Kobayashi Y
Eur Radiol; 2022 Aug; 32(8):5353-5361. PubMed ID: 35201406
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS
Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract][Full Text] [Related]
25. Texture Analysis of Apparent Diffusion Coefficient Maps in Cervical Carcinoma: Correlation with Histopathologic Findings and Prognosis.
Yamada I; Oshima N; Miyasaka N; Wakana K; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Kobayashi D
Radiol Imaging Cancer; 2020 May; 2(3):e190085. PubMed ID: 33778713
[TBL] [Abstract][Full Text] [Related]
26. Association of Apparent Diffusion Coefficient with Disease Recurrence in Patients with Locally Advanced Cervical Cancer Treated with Radical Chemotherapy and Radiation Therapy.
Gladwish A; Milosevic M; Fyles A; Xie J; Halankar J; Metser U; Jiang H; Becker N; Levin W; Manchul L; Foltz W; Han K
Radiology; 2016 Apr; 279(1):158-66. PubMed ID: 26505922
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of diffusion-weighted magnetic resonance imaging and
Park JJ; Kim CK; Park BK
Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
[TBL] [Abstract][Full Text] [Related]
28. Potentialities of multi-b-values diffusion-weighted imaging for predicting efficacy of concurrent chemoradiotherapy in cervical cancer patients.
Liu B; Ma WL; Zhang GW; Sun Z; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y
BMC Med Imaging; 2020 Aug; 20(1):97. PubMed ID: 32799809
[TBL] [Abstract][Full Text] [Related]
29. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
[TBL] [Abstract][Full Text] [Related]
30. The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy.
Zhou G; Chen X; Tang F; Zhou J; Wang Y; Wang Z
Int J Gynecol Cancer; 2016 Feb; 26(2):361-6. PubMed ID: 26807567
[TBL] [Abstract][Full Text] [Related]
31. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
32. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X
Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
Kim HS; Kim CK; Park BK; Huh SJ; Kim B
J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
[TBL] [Abstract][Full Text] [Related]
34. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
[TBL] [Abstract][Full Text] [Related]
35. EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
Vandecasteele K; Tummers P; Van Bockstal M; De Visschere P; Vercauteren T; De Gersem W; Denys H; Naert E; Makar A; De Neve W
BMC Cancer; 2018 Sep; 18(1):898. PubMed ID: 30223802
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy.
Garbajs M; Strojan P; Surlan-Popovic K
Radiol Oncol; 2019 Mar; 53(1):39-48. PubMed ID: 30840595
[TBL] [Abstract][Full Text] [Related]
37. Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT.
Meng J; Liu S; Zhu L; Zhu L; Wang H; Xie L; Guan Y; He J; Yang X; Zhou Z
Sci Rep; 2018 Jul; 8(1):11399. PubMed ID: 30061666
[TBL] [Abstract][Full Text] [Related]
38. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging.
Park JJ; Kim CK; Park BK
Eur Radiol; 2016 Sep; 26(9):3272-9. PubMed ID: 26685853
[TBL] [Abstract][Full Text] [Related]
39. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
40. Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
Takada A; Yokota H; Nemoto MW; Horikoshi T; Matsumoto K; Habu Y; Usui H; Nasu K; Shozu M; Uno T
PLoS One; 2023; 18(3):e0282710. PubMed ID: 37000854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
